Current best practice in the management of hypertensive disorders in pregnancy [0.03%]
妊娠期高血压疾病的当前最佳管理实践
Rosemary Townsend,Patrick O&#x;Brien,Asma Khalil
Rosemary Townsend
Preeclampsia is a potentially serious complication of pregnancy with increasing significance worldwide. Preeclampsia is the cause of 9%-26% of global maternal mortality and a significant proportion of preterm delivery, and maternal and neon...
Lercanidipine/enalapril combination in the management of obesity-related hypertension [0.03%]
用于治疗与肥胖相关高血压的乐卡尼啶/enalapril联合疗法
Guido Grassi
Guido Grassi
Obesity-related hypertension represents a condition frequently observed in current clinical practice characterized by a complex pathophysiological background and a very high cardiovascular risk profile, particularly in severely obese indivi...
Personalized medicine and treatment approaches in hypertension: current perspectives [0.03%]
高血压的个性化医疗和治疗策略：目前的视角
James Brian Byrd
James Brian Byrd
In the US, hypertension affects one in three adults. Current guideline-based treatment of hypertension involves little diagnostic testing. A more personalized approach to the treatment of hypertension might be of use. Several methods of per...
Deborah R Stein,Michael A Ferguson
Deborah R Stein
Hypertensive crises in children are medical emergencies that must be identified, evaluated, and treated promptly and appropriately to prevent end-organ injury and even death. Treatment in the acute setting typically includes continuous intr...
Effectiveness of continuous positive airway pressure in lowering blood pressure in patients with obstructive sleep apnea: a critical review of the literature [0.03%]
持续气道正压治疗对阻塞性睡眠呼吸暂停患者血压影响的文献荟萃分析
Fernanda Fatureto-Borges,Geraldo Lorenzi-Filho,Luciano F Drager
Fernanda Fatureto-Borges
Obstructive sleep apnea (OSA) is an extremely common comorbid condition in patients with hypertension, with a prevalence of ~50%. There is growing evidence suggesting that OSA is a secondary cause of hypertension, associated with both poor ...
Aditya Upadrasta,Ratna Sudha Madempudi
Aditya Upadrasta
Gut microbiota play a significant role in host metabolic processes, and recent metagenomic surveys have revealed that they are involved in host immune modulation and influence host development and physiology (organ development). Initially, ...
Chronic resveratrol reverses a mild angiotensin II-induced pressor effect in a rat model [0.03%]
慢性白藜芦醇逆转血管紧张素II轻度升压作用的实验研究模型中的作用研究
Kevin L Gordish,William H Beierwaltes
Kevin L Gordish
Resveratrol is reported to reduce blood pressure in animal models of hypertension, but the mechanisms are unknown. We have shown that resveratrol infusion increases sodium excretion. We hypothesized that chronic ingestion of resveratrol wou...
The effect of aged garlic extract on blood pressure and other cardiovascular risk factors in uncontrolled hypertensives: the AGE at Heart trial [0.03%]
对难治性高血压患者血压和其他心血管风险因素的衰老大蒜提取物的影响：AGE at Heart试验
Karin Ried,Nikolaj Travica,Avni Sali
Karin Ried
Background: Hypertension affects 30% of adults worldwide. Garlic supplements have shown promise in the treatment of uncontrolled hypertension, and the mechanism of action is biologically plausible. Our trial is the first ...
Clinical use of extended-release oral treprostinil in the treatment of pulmonary arterial hypertension [0.03%]
延长释放型口服曲前列尼尔治疗肺动脉高压的临床应用
Steven C Pugliese,Todd M Bull
Steven C Pugliese
The development of parenteral prostacyclin therapy marked a dramatic breakthrough in the treatment of pulmonary arterial hypertension (PAH). Intravenous (IV) epoprostenol was the first PAH specific therapy and to date, remains the only trea...
Hitesh C Patel,Carl Hayward,Vassilis Vassiliou et al.
Hitesh C Patel et al.
Renal sympathetic denervation (RSD) as a therapy for patients with resistant hypertension has attracted great interest. The majority of studies in this field have demonstrated impressive reductions in blood pressure (BP). However, these tri...